Editorial
Shifting paradigms for treatment of symptomatic aortic stenosis in lower risk populations: role of a newer generation balloonexpandable transcatheter aortic valve implantation device
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S57-S62
.
(16 June 2017)
The prognostic value of residual coronary stenoses after functionally complete revascularisation
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S63-S65
.
(16 June 2017)
Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S66-S68
.
(16 June 2017)
Mesenchymal stromal cell therapy as treatment for ischemic heart failure: the MSC-HF study
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S69-S72
.
(16 June 2017)
Cardiovascular Diagnosis and Therapy (CDT) Editorial: the Minimalist Immediate Mechanical Intervention study
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S73-S76
.
(16 June 2017)
Prognostic superiority of coronary artery bypass grafting to percutaneous coronary intervention in non-diabetic patients with anatomically complex multivessel coronary artery disease
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S77-S81
.
(16 June 2017)
Revascularization strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: urgent or staged?
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S82-S85
.
(16 June 2017)
How far have we come with bioresorbable vascular scaffolds, and where should we go?
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S86-S90
.
(16 June 2017)
The optimal duration of dual antiplatelet therapy after implantation of drug-eluting coronary stents: an unanswered question
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S91-S94
.
(16 June 2017)
Does successful chronic total occlusion recanalization fail to improve long-term survival?
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S95-S97
.
(16 June 2017)
Bioresorbable vascular scaffolds for complex coronary anatomies: “Icarus’ flight” for interventional cardiologists?
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S98-S101
.
(16 June 2017)
Long-term dual antiplatelet therapy and concomitant optimal medical therapy following percutaneous coronary intervention
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S102-S106
.
(16 June 2017)
Requiem for routine thrombus aspiration
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S107-S109
.
(16 June 2017)
Thrombus aspiration in primary percutaneous coronary intervention: still a valid option with improved technique in selected patients!
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S110-S114
.
(16 June 2017)
Editorial to 1-year outcomes of FFRCT-guided care in patients with suspected coronary disease
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S115-S118
.
(16 June 2017)
The relationship between total ischemic time and mortality in patients with STEMI: every second counts
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S119-S124
.
(16 June 2017)
Letter to the Editor
A thoughtful use of CT angiography among patients with prior coronary artery bypass grafts: more lights than shadows?
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S125-S127
.
(16 June 2017)
Triple antithrombotic therapy in patients undergoing percutaneous coronary intervention: balancing between ischemia and bleeding
Cardiovascular Diagnosis and Therapy
2017;
7
(Suppl 2)
:S128-S130
.
(16 June 2017)
Disclosure:
The supplement was published without any sponsorship or funding.